Mauricio Bordonaba is dedicated to transforming the lives of individuals affected by Hemophilia and other Non-Malignant Hematologic diseases by developing and implementing breakthrough therapies worldwide. Currently serving as the Disease Areas Strategy Director at Roche, they lead a cross-functional team to ensure the needs of the Hemophilia community are integral to research and commercialization efforts. Previously, Mauricio held various leadership roles within Roche and Bayer Pharmaceuticals, where they demonstrated success in marketing, sales, and strategy development, contributing to significant business growth and product launches. Mauricio earned a degree in Business Administration from Universidad Iberoamericana in Mexico City.
This person is not in the org chart
This person is not in any teams
This person is not in any offices